UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Insulet
PODD
$9.65B
| $781K | ﹤0.01% |
25,198
+3,000
| +14% | +$88.4K |
|
1752
Enerpac Tool Group
EPAC
$1.92B
| $779K | ﹤0.01% |
33,756
+1,900
| +6% | +$45.5K |
|
|
NPBC
1753
DELISTED
NATL PENN BANCSHARES INC
NPBC
| $779K | ﹤0.01% |
69,095
+9,900
| +17% | +$107K |
|
|
SEM
1754
DELISTED
Select Medical
SEM
| $778K | ﹤0.01% |
89,082
+4,268
| +5% | +$35.8K |
|
1755
Columbia Sportswear
COLM
$2.93B
| $777K | ﹤0.01% |
12,850
+1,900
| +17% | +$113K |
|
|
MZTI
1756
The Marzetti Company
MZTI
$3.02B
| $777K | ﹤0.01% |
8,548
+1,314
| +18% | +$120K |
|
|
RWT
1757
Redwood Trust
RWT
$573M
| $776K | ﹤0.01% |
49,397
+5,400
| +12% | +$91.8K |
|
1758
Gold Fields
GFI
$33.4B
| $775K | ﹤0.01% |
239,975
| – | – |
|
|
ELLI
1759
DELISTED
Ellie Mae Inc
ELLI
| $775K | ﹤0.01% |
11,100
+1,200
| +12% | +$74.7K |
|
1760
Selective Insurance
SIGI
$5.77B
| $769K | ﹤0.01% |
27,398
+1,300
| +5% | +$36.1K |
|
|
LCI
1761
DELISTED
Lannett Company, Inc.
LCI
| $767K | ﹤0.01% |
3,225
+425
| +15% | +$102K |
|
1762
Clearwater Paper
CLW
$369M
| $762K | ﹤0.01% |
13,299
+200
| +2% | +$12.3K |
|
|
INSY
1763
DELISTED
Insys Therapeutics, Inc.
INSY
| $762K | ﹤0.01% |
21,200
+1,100
| +5% | +$34.3K |
|
|
MINI
1764
DELISTED
Mobile Mini Inc
MINI
| $761K | ﹤0.01% |
18,099
+2,200
| +14% | +$90.1K |
|
1765
RBC Bearings
RBC
$17.9B
| $760K | ﹤0.01% |
10,595
+1,795
| +20% | +$132K |
|
|
WEB
1766
DELISTED
Web.com Group, Inc.
WEB
| $760K | ﹤0.01% |
31,399
+4,000
| +15% | +$86.7K |
|
|
BFS
1767
Saul Centers
BFS
$829M
| $759K | ﹤0.01% |
15,432
+500
| +3% | +$26K |
|
|
RDUS
1768
DELISTED
Radius Health, Inc.
RDUS
| $758K | ﹤0.01% |
11,200
+4,700
| +72% | +$219K |
|
1769
Ironwood Pharmaceuticals
IRWD
$701M
| $756K | ﹤0.01% |
74,860
+14,686
| +24% | +$171K |
|
1770
Protolabs
PRLB
$2.1B
| $756K | ﹤0.01% |
11,200
+3,700
| +49% | +$261K |
|
|
FMBI
1771
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $755K | ﹤0.01% |
39,796
+6,500
| +20% | +$116K |
|
1772
Meritage Homes
MTH
$4.71B
| $753K | ﹤0.01% |
31,998
+4,600
| +17% | +$104K |
|
1773
Ubiquiti
UI
$34.3B
| $753K | ﹤0.01% |
23,600
+8,400
| +55% | +$258K |
|
1774
G. Willi-Food International
WILC
$392M
| $751K | ﹤0.01% |
128,895
+4,898
| +4% | +$27.6K |
|
1775
American States Water
AWR
$3.36B
| $750K | ﹤0.01% |
20,051
+900
| +5% | +$34.7K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.